Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin's Lymphoma||
||Other / NIH||
||50||All||18 Years and older (Adult, Senior)||NCT00369681||J0615 CDR0000492792
|May 2006||October 2014||October 2014||August 29, 2006||August 17, 2015||July 3, 2015||